SSS17
/ 3SBio
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
June 18, 2025
A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males
(clinicaltrials.gov)
- P1 | N=6 | Not yet recruiting | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
New P1 trial
June 17, 2025
A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
New P1 trial
June 06, 2025
Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia: A Multicenter RCT
(clinicaltrials.gov)
- P2 | N=90 | Not yet recruiting | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
New P2 trial • Anemia • Hematological Disorders • Orthopedics
June 11, 2025
Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD
(clinicaltrials.gov)
- P2 | N=86 | Completed | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
New P2 trial • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
January 13, 2022
A Phase 1 Study of SSS17 in Healthy Subjects.
(clinicaltrials.gov)
- P1; N=76; Recruiting; Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
May 19, 2021
A Phase 1 Study of SSS17 in Healthy Subjects.
(clinicaltrials.gov)
- P1; N=76; Not yet recruiting; Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Clinical • New P1 trial • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
March 23, 2020
A Study of SSS17 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=65; Not yet recruiting; Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Clinical • New P1 trial
1 to 7
Of
7
Go to page
1